| Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: results from the IMPACC study A Ozonoff, J Schaenman, ND Jayavelu, CE Milliren, CS Calfee, CB Cairns, ... EBioMedicine 83, 104208, 2022 | 36 | 2022 |
| A systematic review of the burden and risk factors of sudden infant death syndrome (SIDS) in Africa GK Osei-Poku, S Thomas, L Mwananyanda, R Lapidot, PA Elliott, ... Journal of Global Health 11, 2021 | 12 | 2021 |
| Features of acute COVID-19 associated with post-acute sequelae of SARS-CoV-2 phenotypes: results from the IMPACC study A Ozonoff, ND Jayavelu, S Liu, E Melamed, CE Milliren, J Qi, LN Geng, ... Nature Communications 15 (1), 216, 2024 | 5 | 2024 |
| The Implication of Sphingolipids in Viral Infections S Thomas, SV Samuel, A Hoch, C Syphurs, J Diray-Arce International Journal of Molecular Sciences 24 (24), 17303, 2023 | 2 | 2023 |
| Human in vitro modeling of adjuvant formulations demonstrates enhancement of immune responses to SARS-CoV-2 antigen S Doss-Gollin, S Thomas, B Brook, K Abedi, C Lebas, F Auderset, ... npj Vaccines 8 (1), 163, 2023 | 2 | 2023 |
| Human In vitro Modeling Identifies Adjuvant Combinations that Unlock Antigen Cross-presentation and Promote T-helper 1 Development in Newborns, Adults and Elders S Thomas, J Pak, S Doss-Gollin, K Ryff, E Beijnen, GK Pedersen, ... Journal of Molecular Biology 436 (4), 168446, 2024 | 1 | 2024 |
| IgM N-glycosylation correlates with COVID-19 severity and rate of complement deposition BS Haslund-Gourley, K Woloszczuk, J Hou, J Connors, G Cusimano, ... Nature Communications 15 (1), 404, 2024 | 1 | 2024 |
| Heterologous SARS-CoV-2 booster vaccine for individuals with hematological malignancies after a primary SARS-CoV-2 mRNA vaccine series AC Sherman, SD van Haren, E Borberg, Z Swank, M Aleissa, A Tong, ... Vaccine, 2024 | | 2024 |
| 1533. The First Ten Years of HIV Preexposure Prophylaxis Use and Missed Opportunities at an Urban Academic Children’s Hospital E Christian, S Thomas, L Ganapathi, D Krakower Open Forum Infectious Diseases 10 (Supplement_2), ofad500. 1368, 2023 | | 2023 |
| Relationship of Heterologous Virus Responses and Outcomes in Hospitalized COVID-19 Patients Y Rosenberg-Hasson, TH Holmes, J Diray-Arce, J Chen, R Kellogg, ... Journal of Immunology (Baltimore, Md.: 1950) 211 (8), 1224-1231, 2023 | | 2023 |
| SEVERE CONGENITAL NEUTROPENIA DUE TO JAGUNAL HOMOLOG 1 (JAGN1) MUTATION: CASE REPORT AND LITERATURE REVIEW S Thomas, G Guenther, JH Rowe, C Platt, A Shimamura, O Levy, ... Frontiers in Pediatrics 11, 1223191, 2023 | | 2023 |
| Through Hills and Valleys. S Thomas The American Journal of Tropical Medicine and Hygiene, 2023 | | 2023 |
| Human in vitro Modeling Characterizes Age-Specific Mechanism of Action of Vaccine Adjuvant Formulations for Global Open Access S Thomas Harvard Medical School, 2023 | | 2023 |
| 1174. Liposomal Co-Formulation of MPL and QS-21 Favors the Development of T-helper 1 Cells and Promotes the Induction of CD8+ T Cells Against SARS-CoV-2 SD van Haren, S Thomas, O Levy, G Sanchez-Schmitz, S Doss-Gollin, ... Open Forum Infectious Diseases 9 (Supplement_2), ofac492. 1011, 2022 | | 2022 |
| Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: results from the IMPACC study (preprint) A Ozonoff, J Schaenman, ND Jayavelu, CE Milliren, CS Calfee, CB Cairns, ... | | 2022 |
| Antimicrobial use in two-week recall of febrile illness: A descriptive study based on Healthcare Utilization Survey in India S Thomas, R Raju, K Ramanujam, A Ks, J John, G Kang International Journal of Infectious Diseases 101, 94-95, 2020 | | 2020 |
